The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ESH AL 2020 | The impact of germline mutations on AML managment
Lucy Godley
• 1 Jul 2020
Lucy Godley, MD, PhD, University of Chicago, Chicago, IL, discusses how the distinction between somatic and germline mutations has a significant impact on the patient’s management as well as important implications for their family members. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
